CAPLIPOINT.NS Cash Flow
Caplin Point Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:40
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹271.65 Cr. | ₹310.98 Cr. | ₹432.37 Cr. | ₹523.23 Cr. | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-217.86 Cr. | ₹-312.63 Cr. | ₹-334.73 Cr. | ₹-582.29 Cr. | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-28.17 Cr. | ₹-38.07 Cr. | ₹-38.32 Cr. | ₹-46.46 Cr. | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹1.18 Cr. | ₹0.86 Cr. | ₹0.00 Cr. | ₹0.25 Cr. | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹26.80 Cr. | ₹-38.86 Cr. | ₹59.32 Cr. | ₹-105.27 Cr. | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹150.76 Cr. | ₹177.56 Cr. | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from CAPLIPOINT.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).